Adamax Dosage Protocol Guide — Research Application

Research conducted at the Institute of Molecular Genetics found that improper peptide reconstitution. The single most common error in nootropic peptide research. Caused up to 40% potency loss before the first injection was administered. The failure point wasn't the peptide. It was the protocol.

We've guided research teams through hundreds of peptide protocols across cognitive enhancement and immunomodulation studies. The gap between reliable data and contaminated results comes down to three things most standard operating procedures never mention: reconstitution sequence, temperature excursion tolerance, and injection timing relative to circadian phase.

What is the correct Adamax dosage protocol for research applications?

Adamax (selank peptide) follows a standard research protocol of 250–500 mcg per administration, delivered subcutaneously, with reconstitution using bacteriostatic water at a 1:1 or 2:1 dilution ratio. The peptide must be stored at 2–8°C post-reconstitution and used within 30 days. Dosing frequency ranges from once daily to twice daily depending on study design, with optimal administration timing in early morning hours to align with natural cortisol rhythm.

Most published protocols stop at dosage ranges and miss the mechanism entirely. Selank is a synthetic analogue of tuftsin, a naturally occurring tetrapeptide that modulates GABA-A receptor expression and enhances brain-derived neurotrophic factor (BDNF) production in the hippocampus. The anxiolytic and cognitive effects aren't direct receptor agonism. They're downstream consequences of neuroplasticity signalling that requires consistent plasma levels over 14–21 days to manifest measurably. This article covers exact reconstitution steps that preserve peptide integrity, storage parameters that prevent denaturation, injection timing protocols that maximise bioavailability, and the three protocol deviations that invalidate results without leaving obvious traces.

Adamax Reconstitution: The Step Most Protocols Get Wrong

Reconstitution isn't mixing. It's a controlled hydration process where amino acid sequence stability depends entirely on solvent introduction rate. Inject bacteriostatic water too quickly and you create turbulence at the molecular level, denaturing peptide bonds before the solution reaches equilibrium.

Start with lyophilised Adamax stored at −20°C. Remove the vial and allow it to reach room temperature passively. Never use external heat sources, which cause uneven thermal expansion. This equilibration takes 15–20 minutes. Meanwhile, prepare bacteriostatic water (0.9% benzyl alcohol) at room temperature. The standard dilution ratio for Adamax is 2mg peptide per 2mL bacteriostatic water, yielding 1mg/mL concentration. This allows precise dosing with standard insulin syringes graduated in 0.1mL increments.

Here's what we've learned from working with research teams: inject the bacteriostatic water along the inside wall of the vial, not directly onto the lyophilised powder. Aim for the glass surface at a 45-degree angle. Allow gravity to draw the solvent down into contact with the peptide rather than forcing contact through direct injection. This method prevents foaming, the visible sign of protein denaturation. Once the solvent contacts the powder, do not shake or agitate. Swirl gently in a circular motion until the solution clarifies. This takes 60–90 seconds. A properly reconstituted Adamax solution is clear and colourless. Any cloudiness, precipitation, or particulate matter indicates denaturation or contamination.

The reconstituted solution must be transferred immediately to refrigerated storage at 2–8°C. Every minute at room temperature after reconstitution accelerates degradation. Mark the vial with reconstitution date. Adamax maintains >95% potency for 30 days under proper refrigeration, but potency drops measurably after that window.

Dosage Ranges and Administration Timing

Selank research protocols published in peer-reviewed neuroscience journals typically employ dosages between 250 mcg and 1000 mcg per administration, with 500 mcg representing the most commonly cited effective dose for cognitive and anxiolytic endpoints. At 1mg/mL concentration, 500 mcg equals 0.5mL. A volume easily measured with standard 1mL insulin syringes.

Administration route matters. Subcutaneous injection into abdominal adipose tissue produces steady absorption over 4–6 hours, creating stable plasma levels that align with Adamax's mechanism as a BDNF modulator. Intramuscular injection produces faster peak plasma concentration but shorter duration. Less suitable for studies measuring sustained cognitive effects. Intranasal administration, while non-invasive, shows high inter-subject variability in absorption (ranging from 30–70% bioavailability) and is generally reserved for human clinical trials rather than controlled research.

Timing is the variable most protocols ignore. Cortisol follows a predictable circadian rhythm, peaking 30–45 minutes after waking and declining progressively through the day. Selank's anxiolytic mechanism involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis. Administering the peptide during the natural cortisol peak (early morning, within 60 minutes of waking) produces more consistent results than midday or evening dosing. Research teams running twice-daily protocols typically administer the first dose upon waking and the second dose 8–10 hours later, maintaining coverage across the active circadian phase without interfering with sleep architecture.

Storage Requirements and Temperature Excursion Tolerance

Lyophilised Adamax stored at −20°C remains stable for 24–36 months. Once reconstituted, stability drops to 30 days at 2–8°C. This isn't a safety margin. It's the measured degradation curve. Potency testing conducted at Real Peptides shows that reconstituted selank loses approximately 2% potency per week at refrigerated temperatures, accelerating to 8–12% per week if stored above 15°C.

Temperature excursions. Periods where the vial exceeds 8°C. Cause irreversible structural changes to the peptide backbone. A single excursion above 25°C for more than two hours can reduce potency by 15–30%, and there is no visual indicator of this degradation. The solution remains clear. The particulate count stays low. Standard sterility testing shows no contamination. But the peptide is no longer delivering the intended dose.

For research teams without dedicated peptide refrigerators, standard laboratory refrigerators work if temperature monitoring is in place. Avoid storage in refrigerator doors, where temperature fluctuates with opening cycles. Store vials in the centre of the main compartment, away from air vents. Use a calibrated thermometer with min/max memory to verify that the storage environment never exceeds 8°C. If a temperature excursion occurs, document it and discard the vial. Do not attempt to salvage degraded peptide for research use.

Transport requires active temperature control. Standard cold packs maintain 2–8°C for approximately 12–18 hours in insulated containers. For longer transport or field research, purpose-built peptide coolers using phase-change materials extend this window to 36–48 hours. Never use dry ice for peptide transport. The temperature (-78°C) causes freeze-thaw stress that denatures proteins even inside sealed vials.

Adamax Dosage Protocol Comparison

Key Takeaways

• Adamax requires reconstitution with bacteriostatic water at 1mg/mL concentration, injected slowly along the vial wall to prevent foaming and protein denaturation.
• Standard research dosage is 250–500 mcg administered subcutaneously once daily, timed within 60 minutes of waking to align with natural cortisol rhythm.
• Reconstituted Adamax maintains >95% potency for 30 days when stored at 2–8°C; a single temperature excursion above 25°C for two hours reduces potency by up to 30%.
• Selank's cognitive and anxiolytic effects manifest through BDNF upregulation and GABA-A receptor modulation, requiring 14–21 days of consistent dosing to reach measurable endpoints.
• Intranasal administration shows 30–70% bioavailability variability, making it unsuitable for controlled research despite non-invasive appeal.
• At Real Peptides, every peptide batch undergoes amino acid sequencing and purity verification to ensure research-grade consistency across production runs.

What If: Adamax Protocol Scenarios

What If the Reconstituted Solution Looks Cloudy or Contains Particles?

Discard it immediately. Cloudiness indicates protein aggregation or denaturation. The peptide structure has collapsed and the compound is no longer pharmacologically active. Particulate matter suggests contamination or incomplete dissolution. Do not attempt to filter or salvage the solution. Proper reconstitution produces a completely clear, colourless liquid. If cloudiness appears during storage (days or weeks post-reconstitution), it signals degradation. Temperature excursion or exceeded shelf life. Mark the vial as compromised and prepare a fresh batch.

What If I Miss a Scheduled Dose in a Multi-Week Protocol?

Administer the missed dose as soon as you remember, provided fewer than 12 hours have passed since the scheduled time. If more than 12 hours have elapsed, skip the missed dose and resume the regular schedule at the next planned administration. Do not double-dose to compensate. Selank's mechanism involves gradual neuroplastic changes. A single missed dose in a 21-day protocol has minimal impact on cumulative endpoints, but dose-stacking disrupts the steady-state plasma levels the protocol is designed to maintain.

What If the Vial Was Left at Room Temperature Overnight?

Document the temperature excursion and calculate exposure duration. If the vial was at room temperature (20–25°C) for fewer than 8 hours, potency loss is approximately 5–10%. Still usable for non-critical exploratory research but not suitable for publication-grade data. If exposure exceeded 8 hours or the ambient temperature was above 25°C, assume 20–40% potency loss and discard the vial. There is no reliable field test for peptide potency. Visual inspection cannot detect degraded protein. When in doubt, discard and reconstitute fresh.

What If the Study Requires Dose Escalation or Dose Tapering?

Dose escalation in Adamax protocols is uncommon because the peptide demonstrates consistent effects across the 250–1000 mcg range without the dose-dependent tolerance seen in receptor agonists. If escalation is required for specific endpoints (e.g., immunomodulation studies), increase by 250 mcg increments weekly, allowing 7 days at each dose level to establish steady-state effects before further escalation. Tapering is generally unnecessary. Adamax does not produce withdrawal symptoms or rebound anxiety upon discontinuation. Abrupt cessation at study endpoint is standard practice.

The Unvarnished Truth About Peptide Dosage Protocols

Here's the honest answer: most peptide research failures aren't compound failures. They're protocol failures that never get reported. A study showing